196 related articles for article (PubMed ID: 36209954)
1. TSNAdb v2.0: The Updated Version of Tumor-specific Neoantigen Database.
Wu J; Chen W; Zhou Y; Chi Y; Hua X; Wu J; Gu X; Chen S; Zhou Z
Genomics Proteomics Bioinformatics; 2023 Apr; 21(2):259-266. PubMed ID: 36209954
[TBL] [Abstract][Full Text] [Related]
2. TSNAD and TSNAdb: The Useful Toolkit for Clinical Application of Tumor-Specific Neoantigens.
Wu J; Zhou Z
Methods Mol Biol; 2023; 2673():167-174. PubMed ID: 37258913
[TBL] [Abstract][Full Text] [Related]
3. TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis.
Wu J; Zhao W; Zhou B; Su Z; Gu X; Zhou Z; Chen S
Genomics Proteomics Bioinformatics; 2018 Aug; 16(4):276-282. PubMed ID: 30223042
[TBL] [Abstract][Full Text] [Related]
4. Neodb: a comprehensive neoantigen database and discovery platform for cancer immunotherapy.
Wu T; Chen J; Diao K; Wang G; Wang J; Yao H; Liu XS
Database (Oxford); 2023 Jun; 2023():. PubMed ID: 37311149
[TBL] [Abstract][Full Text] [Related]
5. GNIFdb: a neoantigen intrinsic feature database for glioma.
Li W; Sun T; Li M; He Y; Li L; Wang L; Wang H; Li J; Wen H; Liu Y; Chen Y; Fan Y; Xin B; Zhang J
Database (Oxford); 2022 Feb; 2022():. PubMed ID: 35150127
[TBL] [Abstract][Full Text] [Related]
6. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract][Full Text] [Related]
7. NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy.
Xia J; Bai P; Fan W; Li Q; Li Y; Wang D; Yin L; Zhou Y
Front Immunol; 2021; 12():644637. PubMed ID: 33927717
[TBL] [Abstract][Full Text] [Related]
8. ProGeo-Neo v2.0: A One-Stop Software for Neoantigen Prediction and Filtering Based on the Proteogenomics Strategy.
Liu C; Zhang Y; Jian X; Tan X; Lu M; Ouyang J; Liu Z; Li Y; Xu L; Chen L; Lin Y; Xie L
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627168
[TBL] [Abstract][Full Text] [Related]
9. Identification of shared neoantigens in esophageal carcinoma by the combination of comprehensive analysis of genomic data and in silico neoantigen prediction.
Yuan Y; Chen C; Liu S; Xiong H; Huang Y; Zhang X; Zhang X; Li B
Cell Immunol; 2022 Jul; 377():104537. PubMed ID: 35636066
[TBL] [Abstract][Full Text] [Related]
10. Neoantigen identification: Technological advances and challenges.
Pu T; Peddle A; Zhu J; Tejpar S; Verbandt S
Methods Cell Biol; 2024; 183():265-302. PubMed ID: 38548414
[TBL] [Abstract][Full Text] [Related]
11. TSNAD v2.0: A one-stop software solution for tumor-specific neoantigen detection.
Zhou Z; Wu J; Ren J; Chen W; Zhao W; Gu X; Chi Y; He Q; Yang B; Wu J; Chen S
Comput Struct Biotechnol J; 2021; 19():4510-4516. PubMed ID: 34471496
[TBL] [Abstract][Full Text] [Related]
12. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
[TBL] [Abstract][Full Text] [Related]
13. Seq2Neo: A Comprehensive Pipeline for Cancer Neoantigen Immunogenicity Prediction.
Diao K; Chen J; Wu T; Wang X; Wang G; Sun X; Zhao X; Wu C; Wang J; Yao H; Gerarduzzi C; Liu XS
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232923
[TBL] [Abstract][Full Text] [Related]
14. [Identification of neoantigens and development of antigen-specific immunotherapy].
Shinohara S; Takahashi Y; Demachi-Okamura A; Matsushita H
Rinsho Ketsueki; 2020; 61(9):1433-1439. PubMed ID: 33162546
[TBL] [Abstract][Full Text] [Related]
15. DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity.
Wu J; Wang W; Zhang J; Zhou B; Zhao W; Su Z; Gu X; Wu J; Zhou Z; Chen S
Front Immunol; 2019; 10():2559. PubMed ID: 31736974
[TBL] [Abstract][Full Text] [Related]
16. dbPepNeo: a manually curated database for human tumor neoantigen peptides.
Tan X; Li D; Huang P; Jian X; Wan H; Wang G; Li Y; Ouyang J; Lin Y; Xie L
Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32090262
[TBL] [Abstract][Full Text] [Related]
17. HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer.
Ren Y; Cherukuri Y; Wickland DP; Sarangi V; Tian S; Carter JM; Mansfield AS; Block MS; Sherman ME; Knutson KL; Lin Y; Asmann YW
Oncoimmunology; 2020; 9(1):1744947. PubMed ID: 32523802
[TBL] [Abstract][Full Text] [Related]
18. Engineering neoantigen vaccines to improve cancer personalized immunotherapy.
Liu Z; Lv J; Dang Q; Liu L; Weng S; Wang L; Zhou Z; Kong Y; Li H; Han Y; Han X
Int J Biol Sci; 2022; 18(15):5607-5623. PubMed ID: 36263174
[TBL] [Abstract][Full Text] [Related]
19. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.
Bai P; Li Y; Zhou Q; Xia J; Wei PC; Deng H; Wu M; Chan SK; Kappler JW; Zhou Y; Tran E; Marrack P; Yin L
Oncoimmunology; 2021 Jan; 10(1):1868130. PubMed ID: 33537173
[TBL] [Abstract][Full Text] [Related]
20. The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space.
Lau TTY; Sefid Dashti ZJ; Titmuss E; Pender A; Topham JT; Bridgers J; Loree JM; Feng X; Pleasance ED; Renouf DJ; Schrader KA; Sun S; Ho C; Marra MA; Laskin J; Karsan A
J Mol Diagn; 2022 Jun; 24(6):609-618. PubMed ID: 35367630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]